ArticleBJC reports2025
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases.
Anna Fager et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it